PureTech Health

News

Respiratory biotech Celea raises $180m, and other financings

This week's collection of venture capital financings in the biotech arena includes rounds for Celea, Beeline, Flare, Lycia, and Telum.

News

PureTech launches lung disease specialist Celea

PureTech launches Celea Therapeutics, tasked with bringing forward a drug that could offer a 'step change' in pulmonary fibrosis treatment.

News

Nektar and PureTech merger talks called off

Just days after revealing that it was in discussions with Nektar Therapeutics over a possible merger, PureTech Health has said the negotiations have been terminated by mutual agreement.

News

PureTech confirms negotiations for a possible Nektar merger

Rumours that Nektar Therapeutics may be talking about a merger with healthcare holding company PureTech have been confirmed by the two companies.

News

PureTech challenges Roche's Esbriet in head-to-head IPF tria...

Roche's idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market, and could come under renewed pressure if another competitor from PureT

R&D